Update on anticoagulant medications for the interventional radiologist

Rakesh Mehta, Matthew S. Johnson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

For many years, available anticoagulant medications were limited to vitamin K antagonists, unfractionated heparin, and aspirin. However, in the past 20 years, several new agents have been developed for the treatment of thrombosis, and even more are being developed. This increasing number of medications has led to more specific treatment algorithms for the care of venous and arterial thrombotic events. As more agents become available, treatment guidelines are rapidly changing. With increasing frequency, interventional radiologists encounter patients already taking anticoagulant medications prophylactically or therapeutically, or they need to determine which anticoagulant medications need to be initiated for a particular procedure. Therefore, it has become increasingly important to understand the mechanisms, risks, and benefits of anticoagulant medications. A review of the traditional anticoagulants, their new counterparts, and their places in the medication repertoire of interventional radiology will be discussed herein.

Original languageEnglish
Pages (from-to)597-612
Number of pages16
JournalJournal of Vascular and Interventional Radiology
Volume17
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Anticoagulants
Interventional Radiology
Vitamin K
Aspirin
Heparin
Thrombosis
Therapeutics
Radiologists
Guidelines

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Update on anticoagulant medications for the interventional radiologist. / Mehta, Rakesh; Johnson, Matthew S.

In: Journal of Vascular and Interventional Radiology, Vol. 17, No. 4, 04.2006, p. 597-612.

Research output: Contribution to journalArticle

@article{d4a935ae241e4ff4b6d8341420283adf,
title = "Update on anticoagulant medications for the interventional radiologist",
abstract = "For many years, available anticoagulant medications were limited to vitamin K antagonists, unfractionated heparin, and aspirin. However, in the past 20 years, several new agents have been developed for the treatment of thrombosis, and even more are being developed. This increasing number of medications has led to more specific treatment algorithms for the care of venous and arterial thrombotic events. As more agents become available, treatment guidelines are rapidly changing. With increasing frequency, interventional radiologists encounter patients already taking anticoagulant medications prophylactically or therapeutically, or they need to determine which anticoagulant medications need to be initiated for a particular procedure. Therefore, it has become increasingly important to understand the mechanisms, risks, and benefits of anticoagulant medications. A review of the traditional anticoagulants, their new counterparts, and their places in the medication repertoire of interventional radiology will be discussed herein.",
author = "Rakesh Mehta and Johnson, {Matthew S.}",
year = "2006",
month = "4",
doi = "10.1097/01.RVI.0000209226.54671.42",
language = "English",
volume = "17",
pages = "597--612",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Update on anticoagulant medications for the interventional radiologist

AU - Mehta, Rakesh

AU - Johnson, Matthew S.

PY - 2006/4

Y1 - 2006/4

N2 - For many years, available anticoagulant medications were limited to vitamin K antagonists, unfractionated heparin, and aspirin. However, in the past 20 years, several new agents have been developed for the treatment of thrombosis, and even more are being developed. This increasing number of medications has led to more specific treatment algorithms for the care of venous and arterial thrombotic events. As more agents become available, treatment guidelines are rapidly changing. With increasing frequency, interventional radiologists encounter patients already taking anticoagulant medications prophylactically or therapeutically, or they need to determine which anticoagulant medications need to be initiated for a particular procedure. Therefore, it has become increasingly important to understand the mechanisms, risks, and benefits of anticoagulant medications. A review of the traditional anticoagulants, their new counterparts, and their places in the medication repertoire of interventional radiology will be discussed herein.

AB - For many years, available anticoagulant medications were limited to vitamin K antagonists, unfractionated heparin, and aspirin. However, in the past 20 years, several new agents have been developed for the treatment of thrombosis, and even more are being developed. This increasing number of medications has led to more specific treatment algorithms for the care of venous and arterial thrombotic events. As more agents become available, treatment guidelines are rapidly changing. With increasing frequency, interventional radiologists encounter patients already taking anticoagulant medications prophylactically or therapeutically, or they need to determine which anticoagulant medications need to be initiated for a particular procedure. Therefore, it has become increasingly important to understand the mechanisms, risks, and benefits of anticoagulant medications. A review of the traditional anticoagulants, their new counterparts, and their places in the medication repertoire of interventional radiology will be discussed herein.

UR - http://www.scopus.com/inward/record.url?scp=33747884342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747884342&partnerID=8YFLogxK

U2 - 10.1097/01.RVI.0000209226.54671.42

DO - 10.1097/01.RVI.0000209226.54671.42

M3 - Article

VL - 17

SP - 597

EP - 612

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 4

ER -